9
total announcements
532488.BO · 15 min delayed
Divis Laboratories Ltd
Divis Laboratories Ltd has submitted the Scrutinizer's report on the 36th AGM resolutions, stating that all resolutions were passed with requisite majority. The meeting was held on August 10, 2026, through video conferencing, with 150 members attending and representing 12,42,61,211 shares.
Divis Laboratories Ltd
Divis Laboratories Ltd held its 36th AGM on August 10, 2026, through video conferencing. The meeting was attended by 150 members representing 12,42,61,211 shares. All resolutions were passed with requisite majority. The company provided webcast facility and electronic voting for members. The Statutory Auditor's Report and Secretarial Auditor's Report for the year ended March 31, 2026, were presented without any qualifications, observations, or adverse comments.
Divis Laboratories Ltd
Divis Laboratories Ltd submitted the transcript of the earnings conference call held on August 01, 2026, for the quarter ended June 30, 2026. The transcript is available on the company's website.
Divis Laboratories Ltd
Divis Laboratories Ltd has published unaudited financial results for the quarter ended June 30, 2026, as reported in newspapers Financial Express and Andhra Prabha.
Divis Laboratories Ltd
Divis Laboratories Ltd has uploaded the audio recording of its Q1FY27 earnings conference call on its website.
Divis Laboratories Ltd
Divis Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and approved the appointment of two senior management personnel. The company's revenue from operations was ₹2974 crores, and its profit before exceptional items and tax was ₹1165 crores.
Divis Laboratories Ltd
Divis Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹2974 crore and profit for the period at ₹891 crore. The company has also approved the appointment of two senior management personnel.
Divis Laboratories Ltd
Divis Laboratories Ltd announced the retirement of two senior management personnel, Mr. L. Ramesh Babu and Mr. D. Madhu Babu, effective July 31, 2026. The company informed the stock exchange about the cessation of these personnel as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Divis Laboratories Ltd
Divi's Laboratories Ltd has announced the schedule of earnings conference call for Q1 FY27, to be held on August 1, 2026, to discuss the company's unaudited financial results for the quarter ended June 30, 2026.